With a sharp focus on unique, noninvasive platform technologies, Helius Medical Technologies (Helius) is the medical device holding company working to expand treatment options for patients by amplifying the brain’s ability to heal itself.
Location: United States
Employees: 11-50
Total raised: $500M
Founded date: 2014
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.09.2025 | - | $500M | Pantera |
Mentions in press and media 20
| Date | Title | Description |
| 17.09.2025 | Helius Raises Over $500 Million to Establish SOL Treasury Company | Helius Medical Technologies has completed an oversubscribed private investment in public equity offering, securing more than $500 million through the sale of common stock and pre-funded warrants priced at $6.881, along with stapled warrants... |
| 15.09.2025 | Pantera Launches SOL Treasury Company, Pursues PIPE, Republic Digital Invests | Pantera Capital has partnered with Summer Capital to create a SOL treasury company. The plan was originally revealed last month. SOL is the native digital asset of Solana. According to a public release, Helius Medical Technologies, Inc. (Na... |
| 12.03.2024 | Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke | - |
| 07.03.2024 | Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference | - |
| 04.10.2022 | ROTH Capital Partners to Host Inaugural Healthcare Opportunities Conference on October 6th at the Yale Club in New York City | Event to feature company presentations and one-on-one meetings between institutional investors and senior management from select Healthcare companies in Biotechnology, Pharmaceuticals, Medical Technologies, Oncology and Mental Health Therap... |
| 13.11.2021 | Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option | NEWTOWN, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the closing of its previously announced unde... |
| 11.11.2021 | Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial Results - Form 8-K | Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial Results NEWTOWN, Pa., November 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech ... |
| 11.11.2021 | Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial Results | NEWTOWN, Pa., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended Septem... |
| 10.11.2021 | Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common Stock | NEWTOWN, Pa., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the pricing of an underwritten registered pu... |
| 10.11.2021 | Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common Stock | NEWTOWN, Pa., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the pricing of an underwritten registered pu... |
Show more